QBIO   $0.014  -3.57% Market Open

Last Events:

2023-03-30 Trend pattern changed from Not found to расходящийся клин с наклоном вверх.

2023-03-30 Signal in Stochastic changed from bullish reversal to bullish. The stochastic indicator is in the upper part of the neutral territory and it grows. These factors indicate that positive dynamics persists. Last signal: up-crossing the middle level.

2023-03-30 Signal in MACD changed from bullish to bullish recovery. Oscillator MACD is in the positive territory it's lower than the signal line and grows. These factors mean that positive mood prevails, but this trend does not have a significant strength. Last signal: main and signal line crossing.

2023-03-30 Signal in RSI changed from bearish reversal to bullish weakening. RSI indicator is in the upper part of the neutral territory and it heading south. These factors indicate that the downside trend is forming. Last signal: entrance to the overbought zone.

2023-03-30 Signal in EMA100 changed from bearish reversal to n/a. 2022-07-29 the price crossed down the moving average line and getting closer to the MA, which means that the downside trend weakens.

2023-03-29 Trend pattern changed from расходящийся клин с наклоном вверх to Not found.

2023-03-29 Signal in Stochastic changed from bullish to bullish reversal. The stochastic indicator is in the lower part of the neutral territory and it grows. These factors indicate that the upside trend is confirmed. Last signal: main and signal line crossing.

2023-03-29 Signal in MACD changed from bullish recovery to bullish. Oscillator MACD is in the positive territory it's higher than the signal line and grows. These factors mean that positive mood prevails. Last signal: up-crossing the middle level.


Current temperature: 0.40
ST: 0, Cor:

50-50 Year Forecast
Low with 42% probability: 0.01
Target: 6.00
High with 41% probability: 0.67
Analyst Recommendations:
Number of estimates 1
Target Price Mean 6.00
Mean unverified/preliminary 6.00 / 6.00
Target Price Low / High 6.00 / 6.00
Median / STD DEV 6.00 / 0.00
Tech Forecasts:
More signals
  < 1M 1-3M > 3M
total Sell Sell Sell
rsi Sell Sell Sell
macd - Sell -
stoch - - -
ma20 Sell Sell Sell
ma50 - - -
ma100 Sell Sell Sell
Candlestick PatternFeb. 24, 2023 Doji - is formed when the open and the close are the same or very close. The body of candle is small. The length of the shadows are not important. The appearance of a Doji should alert the investor of major indecision.
ISIN US74736N1054
ceo Mr. Denis D. Corin
Website https://www.qbiomed.com
Q BioMed Inc., a biomedical acceleration and development company, focuses on licensing, acquiring, and providing resources to life sciences and healthcare companies. The company offers Strontium Chloride Sr-89 and Metastron, a radiopharmaceutical therapeutic for the treatment of metastatic bone cancer pain. It is also developing Man-01, that is used for the treatment of primary open angle glaucoma; QBM-001 for rare pediatric non-verbal autism spectrum disorder; and Uttroside-B, a novel chemotherapeutic for liver cancer. Q BioMed Inc. has a partnership with Mannin Research Inc. for the development of therapeutic drugs to treat acute respiratory distress syndrome, glaucoma, kidney diseases, and others. The company was formerly known as ISMO Tech Solutions, Inc. and changed its name to Q BioMed Inc. in July 2015. Q BioMed Inc. was incorporated in 2013 and is based in New York, New York.